Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma

NCT04497688 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Hodgkin's Lymphoma

Interventions

DRUG: PEG-rhG-CSF

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Collaborators

[object Object]